Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL30P15 (Ribosomal protein L30 pseudogene 15) is a human processed pseudogene that originates from the ribosomal protein L30 gene. Processed pseudogenes are genomic sequences that arise from retrotransposition events and usually lack the regulatory elements necessary for gene expression. As a pseudogene, RPL30P15 does not code for a functional protein and has no known physiological or pathological role, drug interactions, or biomarker utility. Ribosomal protein L30 is a component of the large 60S ribosomal subunit, but RPL30P15 itself is non-coding[8][2][4]. *Note:* If you are seeking a functional ribosomal protein, refer to the parent gene **RPL30 (Ribosomal protein L30)**, not this pseudogene[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L30 pseudogene 15 (RPL30P15).